Leukotriene modifiers: New drugs, old and new reactions

Journal of Allergy and Clinical Immunology

Volumn 103, Issue 3 II, 1999, Pages 374-375

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ANTIASTHMATIC AGENT; FLUTICASONE PROPIONATE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MONTELUKAST; NEW DRUG; PRANLUKAST; SALMETEROL XINAFOATE; ZAFIRLUKAST;

ASTHMA; CHILD; CHILDHOOD DISEASE; CHURG STRAUSS SYNDROME; DRUG INDUCED DISEASE; EDITORIAL; HUMAN; INHALATIONAL DRUG ADMINISTRATION; LUPUS ERYTHEMATOSUS; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; TREATMENT OUTCOME;

ACETATES; ANTI-ASTHMATIC AGENTS; ASTHMA; AUTOIMMUNE DISEASES; CHROMONES; CHURG-STRAUSS SYNDROME; DRUG HYPERSENSITIVITY; EOSINOPHILIA; HUMANS; LEUKOTRIENE ANTAGONISTS; LEUKOTRIENES; LUPUS ERYTHEMATOSUS, SYSTEMIC; QUINOLINES; TH2 CELLS; TOSYL COMPOUNDS;

EID: 0032976923     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0091-6749(99)70459-8     Document Type: Article

References (5)

1. Finkel TH, Hunter DJ, Paisley JE, Finkel RS, Larsen GL. Drug-induced lupus in a child after treatment with zafirlukast (Accolate). J Allergy Clin Immunol 1999;103:533-4.
2. Adkinson NF Jr. Drug Allergy. In: Middleton E Jr, Reed CE, Ellis EF, Adkinson NF Jr, Yunginger JW, Busse WW, editors. Allergy: principles and practice. 5th ed. St. Louis: Mosby; 1998. p. 1212-24.
3. Rosenwasser LJ. The vasculitic syndromes and the polyarteritis nodosa group. In: Bennett JC, Plum F, editors. Cecil textbook of medicine. Philadelphia: W.B. Saunders; 1996. p. 1490-5.
4. Wechsler ME, Garpestad E, Flier SR, Kocher O, Weiland DA, Polito AJ, et al. Pulmonary infiltrates, eosinophilia, and cardiomyopathy following corticosteroid withdrawal in patients with asthma receiving zafirlukast. JAMA 1998;279:455-7.
5. Kinoshita M, Shiraishi T, Koga T, Ayabe M, Rikimaru T, Oizumi K. Churg-Strauss syndrome after corticosteroid withdrawal in an asthmatic patient treated with pranlukast. J Allergy Clin Immunol 1999;103:534-5.